Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Biotechnology
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces Second Quarter Results for Fiscal 2023

Business Wire May 25, 2023

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2023 Financial Results

Business Wire May 23, 2023

Covalon, Leader in Compassionate Pediatric Infection Prevention Solutions, to Participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023

Business Wire May 16, 2023

Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in Toronto

PR Newswire April 26, 2023

Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination

PR Newswire March 27, 2023

Leader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023

PR Newswire March 20, 2023

Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders

PR Newswire March 9, 2023

Covalon Welcomes Martin Goldfarb, O.C., to its Board of Directors

PR Newswire March 9, 2023

Covalon To Hold Annual and Special Meeting of Shareholders on Wednesday, March 8, 2023

PR Newswire February 28, 2023

Covalon Announces Improved First Quarter Fiscal 2023 Results

PR Newswire February 23, 2023

Infection Prevention Solutions Provider Covalon to Participate for the First Time in NEO - The Conference for Neonatology in Las Vegas, NV on February 22-24, 2023

PR Newswire February 20, 2023

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2023 Financial Results

PR Newswire February 17, 2023

Covalon Announces Fourth Quarter and Year End Results for Fiscal 2022 and Highlights Company Transformation Changes

PR Newswire January 25, 2023

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2022 Financial Results

PR Newswire January 23, 2023

Covalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's Hospital

Canada NewsWire November 21, 2022

Covalon Launches New "CLABSI Conscious" Campaign to Help Children Heal Without Infections

PR Newswire November 8, 2022

Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds

PR Newswire November 1, 2022

Covalon to Participate in the American Nurses Credentialing Center Magnet Conference in Philadelphia

Canada NewsWire October 11, 2022

Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto

PR Newswire September 28, 2022

Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting

PR Newswire September 26, 2022